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The COP9 signalosome (CSN) is an essential regulator of cullin-RING-ubi-
quitin (Ub) ligases (CRLs), which ubiquitinate important cellular regula-
tors and target them for degradation by the Ub proteasome system (UPS).
The CSN exhibits deneddylating activity localized on subunit CSN5, which
removes the ubiquitin-like protein Nedd8 from the cullins of CRLs. CSN-
mediated deneddylation is an important step in the process of CRL remod-
eling, in which new substrate recognition units are incorporated into Ub
ligases to meet changed requirements for proteolysis in cells. For instance,
extensive CRL remodeling occurs during adipogenic differentiation when
new CRL3s are formed. Diversification of CSN complexes during evolu-
tion is most likely another adaptation to meet different cellular require-
ments. Best known CSN variants are formed by different CSN subunit
isoforms. For instance, in plant cells, isoforms have been identified for the
MPN-domain subunits CSN5 (CSN5A and CSN5B) and CSN6 (CSN6A
and CSN6B) which form four distinct CSN variants. In mammalian cells
CSNCSN7A and CSNCSN7B variants are generated by CSN7 isoforms. We
demonstrate that the two variants coexist in human LiSa-2 cells and in
mouse embryonic fibroblasts. During adipogenic differentiation of LiSa-2
cells CSN7B increases in parallel with an elevation of the total CSN com-
plex. Permanent overexpression of Flag-CSN7B but not of Flag-CSN7A
accelerates adipogenesis in LiSa-2 cells indicating a specific function of the
CSNCSN7B variant in stimulating adipogenesis. Silencing of CSN7A as well
as of CSN7B in LiSa-2 cells and in mouse embryonic fibroblasts (MEFs)
reduces adipogenic differentiation demonstrating that both CSNCSN7A and
CSNCSN7B variants are involved in the process.
The mammalian COP9 signalosome (CSN) is a hetero-
octameric complex consisting of subunits CSN1–CSN8
[1,2]. As shown by mass spectrometry (MS) [3,4], cryo-
electron microscopy (cryo-EM) [5] and crystal struc-
ture analysis [6] each complex contains a single copy
of each subunit. It is composed of six Proteasome-
COP9 signalosome-Initiation factor eIF3 (PCI)-
domain subunits including CSN1-4, CSN7, and CSN8
and two MOV34-Pad1-N-terminal (MPN)-domain
subunits called CSN5 and CSN6.
Abbreviations
CAND1, cullin-associated and neddylation-dissociated 1; CRL, cullin-RING-ubiquitin Ligase; CSN, COP9 signalosome; MEFs, mouse
embryonic fibroblasts; MPN, MOV34-Pad1-N-terminal; ORO, Oil-Red-O; PCI, proteasome-COP9 signalosome-Initiation factor eIF3; SRS,
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Increased diversification of the CSN complexes dur-
ing evolution potentially allowed interactions with dif-
ferent binding partners and substrates as well as
diverse expression profiles that meet different cellular
requirements. Diversification of CSN variants devel-
oped by varying CSN subunit isoforms originated
from gene duplication [4,7–10] or by alternative trans-
lation forms as shown for CSN8 [11]. For instance, in
plant cells isoforms have been identified for the MPN-
domain subunits CSN5 (CSN5A and CSN5B) and
CSN6 (CSN6A and CSN6B) [8,12]. In Arabidopsis,
CSN5A and CSN5B assemble into distinct CSN com-
plexes, whereas CSNCSN5A-containing variant is the
dominant form [4,12]. Most importantly, CSN5A- and
CSN5B-containing variants play unique roles in plant
development [4,8].
Endogenous CSNCSN7A and CSNCSN7B variants
coexist in human red blood cells [1,3]. In other mam-
malian cells, CSN7A and CSN7B are coexpressed as
well [10]. CSN7A and CSN7B possess 59% protein
sequence identity (see Fig. 1A) [7]. According to the
NCBI databank, the CSN7A gene is localized on chro-
mosome 12, whereas the CSN7B gene was mapped to
chromosome 2. At present, CSN7A and CSN7B
expression profiles or CSNCSN7A and CSNCSN7B com-
plex functions are unknown. According to the Gen-
evestigator expression data library CSN7A (COPS7A)
and CSN7B (COPS7B) are expressed in all human
cells and tissues investigated. The two CSN8 isoforms
arise from the alternative translation initiation sites
Met1 (CSN8A) or Met6 (CSN8B) [11]. The two alter-
native translation initiation sites and the fact that
CSN8A as well as CSN8B are integrated into distinct
CSN complexes were confirmed by MS analysis [7].
The CSN is a metalloprotease with a MPN+/JAMM
motif and, hence, belongs to the JAMM family of deu-
biquitinating enzymes (DUBs). CSN5 has the catalytic
centre and it needs structural rearrangements in the
CSN holo complex for its activation [6,13]. It is
responsible for the CSN-mediated removal of Nedd8
from cullins called deneddylation [14]. The CSN is
highly specific for neddylated cullin as substrate [5,15].
The CSN forms supercomplexes with cullin-RING
ubiquitin (Ub) ligases (CRLs) comprising the largest
family of Ub ligases with more than 250 members
[16,17]. The cullin family (Cul1-7) provides the scaffold
for CRL complexes. The C-terminal part of the cullins
is associated with the RING H2 finger proteins, Rbx1
or Rbx2, which bind the E2 with the activated Ub. Sub-
strate-adaptor proteins (Skp1, elongin C, or DDB1) are
associated with the N-terminal part of cullins. They
recruit substrate recognition subunits (SRSs) to the
complex [18] such as F-box proteins (FBP) in case of
Cul1 complexes (CRL1) and BTB proteins for CRL3s
[17,19,20]. Deneddylation by the CSN protects CRL
components from autoubiquitination [21]. In addition,
it is a first step in the remodeling of CRLs, an adapta-
tion to changed substrate specificity requirements in
cells. The Cullin-Associated and Neddylation-Disso-
ciated 1 (CAND1) binds to deneddylated cullins and
acts as a protein exchange factor for CRL1FBP. It aug-
ments the dissociation of Skp1-FBP modules by mil-
lion-fold [22]. This allows the recruitment of a new FBP
to Cul1. Depletion of CAND1 in Schizosaccaromyces
pombe [23], in Saccharomyces cerevisiae [24] or in
human cells [22,25] profoundly alters the cellular reper-
toire of CRL1 complexes. Recently we have shown that
CAND1 is an exchange factor for CRL3s as well [26].
Together with the ubiquitin proteasome system
(UPS), the CSN is responsible for cell cycle progression
[27], DNA repair [27,28], cell differentiation [29–31],
development [2,29,31], and tumorigenesis [32,33]. More
recently we have shown that the CSN has a function in
adipocyte differentiation [34]. Adipogenesis is main-
tained by an interplay between essential transcription
factors such as peroxisome proliferator-activated recep-
tor c (PPAR-c), the CCAAT/enhancer-binding proteins
a and b (CC/EBPa and b), and their antagonist CCAAT
enhancer-binding homologous protein (CHOP). Most
of the key regulators of adipogenesis are targeted by the
UPS [35,36]. CHOP is ubiquitinated via CRL3 contain-
ing the SRS Keap1 [34], which is integrated into CRL3
complexes in a CAND1-dependent manner [26]. Per-
manent downregulation of CSN1 subunit leads to an
increase in CHOP and completely blocks adipogenesis
[34] demonstrating a pivotal role for the CSN in adipo-
cyte differentiation.
At the moment it is unclear whether CSNCSN7A and
CSNCSN7B variants possess different characteristics
including altered affinities to CSN-associated proteins
such as CRLs. Moreover, it is obscure whether
CSNCSN7A or CSNCSN7B or both are necessary for adi-
pogenesis. Here, we show that CSNCSN7A and
CSNCSN7B variants coexist in human LiSa-2 preadipo-
cytes. While overexpression of CSN7A or CSN7B
caused different effects on adipogenic differentiation in
LiSa-2 cells, downregulation of CSN7A as well as
CSN7B led to retardation of adipogenesis.
Results and Discussion
In LiSa-2 cells distinct CSNCSN7A and CSNCSN7B
variants coexist
Using specific antibodies for CSN7A and CSN7B
endogenous CSN complexes were immunoprecipitated
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from LiSa-2 cell lysates (see Fig. 1B). Selected CSN
subunits were detected by western blotting in the pre-
cipitates indicating the existence of distinct CSN7A- as
well as CSN7B-containing complexes. In addition, the
CSN-associated proteins Cul1, Cul3, the F-box protein
b-TrCP, and the ubiquitin-specific protease 15
(USP15) were identified in the same precipitates
(Fig. 1B). To address the question about the composi-
tion and interactions of CSNCSN7A and CSNCSN7B
complexes, we established LiSa-2 cell lines that stably
express Flag-CSN7A or Flag-CSN7B. This method
has been successfully applied with permanently
expressed Flag-CSN2 in mouse B8 fibroblasts in which
approximately 50% of endogenous CSN incorporated
Fig. 1. LiSa-2 cells exhibit distinct
CSNCSN7A and CSNCSN7B variants. (A)
Sequence alignment of human CSN7A and
CSN7B protein. The PCI domains of the
two isoforms are localized in the middle of
the protein (red). Putative PKC (green) and
CK2 (blue) phosphorylation sites are
distributed differently throughout the
molecules. (B) Immunoprecipitation (IP)
with LiSa-2 cells using specific anti-CSN7A
or CSN7B antibodies and western blotting
(WB) using antibodies against selected
CSN subunits and CSN-associated
proteins. (C) Lysates of Flag-CSN7A-LiSa-2
cells and of Flag-CSN7B-LiSa-2 cells were
analyzed with indicated antibodies by
western blotting (left panel). Flag-
pulldowns and subsequent elution by Flag
peptide were performed and the eluated
proteins were tested with indicated
antibodies (right panel). (D) Density
gradient centrifugation of lysates from
Flag-CSN7A-LiSa-2 cells (left panel) and
Flag-CSN7B-LiSa-2 cells (right panel).
Western blots were performed with
indicated antibodies. As calibrated, under
these conditions the CSN peak
sedimented into fractions 8, 9, and 10 (red
box).
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Flag-CSN2 [37]. Moreover, recently we have shown
that Flag-pulldowns are proper alternatives for CSN
isolation [5] compared to the time consuming CSN
preparation from red blood cells [38]. Flag-CSN7A-
LiSa-2 and Flag-CSN7B-LiSa-2 cells were tested by
western blotting (Fig. 1C, left panel). Specific anti-
CSN7A and anti-CSN7B antibodies were used to
detect endogenous CSN7A and CSN7B and overex-
pressed Flag-CSN7A and Flag-CSN7B in LiSa-2 cells.
As seen in Fig. 1C, left panel (Lysate) the expression
of Flag-CSN7A in Flag-CSN7A-LiSa-2 cells and the
expression of Flag-CSN7B in Flag-CSN7B-LiSa-2 cells
amounted to about 20–30% of endogenous CSN7A or
CSN7B, respectively. Data obtained with LiSa-2 cell
lysate (Fig. 1C, left panel) clearly show a coexpression
of endogenous CSN7A and CSN7B in these cells. It
seems that CSN7A is less expressed as compared to
CSN7B. On the other hand, the anti-CSN7A antibody
seems to be less efficient as compared to the anti-
CSN7B antibody. The anti-Flag-antibody showed a
nice reaction with Flag-CSN7A as well as with Flag-
CSN7B, indicating reduced expression of Flag-CSN7A
as compared to Flag-CSN7B in LiSa-2 cells.
Cells were lysed and Flag-pulldowns were performed
as described [37]. In Fig. 1C, right panel, all eight CSN
subunits were detected in CSNFlag-CSN7A as well as in
CSNFlag-CSN7B complexes. Using specific anti-CSN7A
and anti-CSN7B antibodies revealed that no CSN7B was
detected in CSNFlag-CSN7A and no CSN7A in CSNFlag-
CSN7B pulldowns (Fig. 1C, right panel). Interestingly,
Flag-pulldowns indicated that relatively more USP15, b-
TrCP, Cul1, and Cul3 were associated with CSNFlag-
CSN7A as compared to CSNFlag-CSN7B complexes.
Density gradient centrifugation as shown in Fig. 1D
was performed to check the integration of Flag-tagged
CSN7A and CSN7B into endogenous CSN complexes
in Flag-CSN7A-LiSa-2 and in Flag-CSN7B-LiSa-2
cells. As visualized by the anti-Flag-antibody, the
majority of both Flag-CSN7A and Flag-CSN7B sedi-
mented into the peak fractions of the CSN.
Overexpression of Flag-CSN7B, but not of Flag-
CSN7A, accelerates adipogenic differentiation in
LiSa-2 cells
During LiSa-2 cell adipogenesis the expression of CSN
subunits increases [26]. Permanent downregulation of
CSN expression blocks adipogenesis [34]. To estimate
relative amounts of endogenous CSN7A and CSN7B
protein in control cells (siGFP cells) during adipogene-
sis we used data from three experiments. LiSa-2 cells
treated with siGFP, siCSN7A, and siCSN7B were
stimulated for adipogenesis (see Fig. 4A) using a hor-
mone cocktail consisting of insulin, triiodthyronine,
and cortisol as described before [34,39]. After 1, 8, and
15 days, cells were lysed and lysates were probed with
indicated antibodies. Bands obtained from controls
(siGFP) as presented in Fig. 4A were determined by
Fig. 1. Continued.
Fig. 2. Dynamics of endogenous CSN7A and CSN7B expression
levels during adipogenesis. LiSa-2 cells treated with siGFP were
stimulated for adipogenesis using a hormone cocktail and after 1,
8, and 15 days cells were lysed for analysis. Western blots of
endogenous CSN7A and CSN7B data from control cells (siGFP
cells) as shown in Fig. 4A were quantified by densitometry. CSN7A
occurs as a doublet. Based on the molecular mass the lower band
was used for calculation. Results were normalized to c-tubulin and
calculated as relative amount per day of adipogenesis. Data of
three independent experiments are expressed in means  SD.
Statistical significance is indicated (P < 0.05).
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densitometry and normalized against c-tubulin. As
shown in Fig. 2, at the beginning of adipogenesis (day
1) CSN7A protein levels were higher as compared to
CSN7B. However, during adipogenesis CSN7B expres-
sion level increased significantly reaching the expres-
sion levels of CSN7A on day 8 and 15, whereas
CSN7A expression did not change significantly.
The western blot in Fig. 3A shows the impact of
permanent overexpression of Flag-CSN7A or Flag-
CSN7B on regulators of adipogenesis. PPAR-c is a
master regulator of adipogenesis which is also
characterized by an increase in neddylated Cul3 [26]
and by downregulation of CHOP [34]. The anti-Flag
antibody indicates the overexpression of Flag-CSN7A
or Flag-CSN7B. Figure 3A clearly demonstrates that
overexpression of Flag-CSN7B caused an induction of
PPAR-c expression, an early accumulation of neddy-
lated Cul3 as well as a downregulation of CHOP. This
parallels with an increased formation of lipid droplets
(LD) as visualized by Oil-Red-O (ORO) staining
(Fig. 3B). LiSa-2 cells permanently expressing Flag-
CSN7B showed a significantly accelerated adipogenesis
Fig. 3. Dynamics of Cul1, Cul3, PPAR-c,
and CHOP expression during adipogenesis
in response to Flag-CSN7A or Flag-CSN7B
overexpression in LiSa-2 cells. (A) Western
blotting with lysates from LiSa-2 cells
(controls), Flag-CSN7A-LiSa-2 cells and
Flag-CSN7B-LiSa-2 cells using indicated
antibodies. After stimulation of
adipogenesis cells were lysed at day 1, 8,
and 15 and analyzed by western blotting.
(B) Lipid droplet formation was visualized
by staining with ORO and light microscopy
after day 1, 8, and 15 of adipogenic
differentiation.
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Fig. 4. Transient silencing of CSN7A or
CSN7B during adipogenesis in LiSa-2 cells.
LiSa-2 cells were transiently transfected
with siRNA against CSN7A (siCSN7A) or
CSN7B (siCSN7B). (A) Adipogenesis was
induced and after indicated times western
blots were performed with indicated
antibodies. (B) LiSa-2 cells transiently
transfected with siRNA against CSN7A or
CSN7B were stained with ORO, which
was quantified by photometry (see
Materials and Methods). Data obtained
from four independent experiments are
expressed as means  SEM. Statistical
significance is indicated. (C) Lipid droplet
formation was visualized by staining with
ORO and light microscopy in control cells
(siGFP) and LiSa-2 cells transfected with
siRNA against CSN7A (siCSN7A) and
CSN7B (siCSN7B).
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in comparison to Flag-CSN7A-LiSa-2 and control
cells.
Silencing of CSN7A and CSN7B retards
adipogenesis in LiSa-2 cells as well as in mouse
embryonic fibroblasts
To investigate the impact of CSN7A and CSN7B on
the dynamics of adipogenesis regulators, we transiently
downregulated CSN7A or CSN7B with specific siRNA
during the differentiation of LiSa-2 cells. As shown in
the western blot in Fig. 4A, downregulation of
CSN7A as well as CSN7B led to a reduction in
PPAR-c and an increase in CHOP after 1 and 8 days
of differentiation. As expected, after 15 days of differ-
entiation, the effect of transient transfection was neu-
tralized and protein concentrations were normalized.
ORO staining was performed to quantify lipid produc-
tion during adipogenesis. As demonstrated in Fig. 4B,
there was a significant reduction of lipid production in
response to CSN7A as well as CSN7B downregulation
after 8 days of differentiation. The corresponding
microscopy in Fig. 4C shows retarded LD production
upon silencing of both CSN7A and CSN7B.
To confirm the effect of CSN7A and CSN7B silenc-
ing on adipogenesis in another model system for adi-
pogenic differentiation we used mouse embryonic
fibroblasts (MEFs) [40]. Using a specific hormone
cocktail (see Materials and Methods) adipogenic dif-
ferentiation can be induced in MEFs. Figure 5 sum-
marizes data obtained after 7 days differentiation of
MEFs. Similar as in LiSa-2 cells, downregulation of
CSN7A as well as of CSN7B reduced the expression
of PPAR-c and increased the level of CHOP as com-
pared to siGFP controls (Fig. 5A). Likewise, as
demonstrated in Fig. 5B, ORO staining revealed a
retardation of LD formation after transient silencing
of CSN7A as well as CSN7B on day 7 of MEF differ-
entiation. Unfortunately downregulation of CSN7A
led to accompanied reduction of CSN7B and vice
versa. At the moment, the reason for this effect is
unclear.
Acceleration of adipogenesis in Flag-CSN7B-LiSa-
2 cells specifically depends on the increase of
CSN7B
LiSa-2 cells stably expressing Flag-CSN7B resulting in
accelerated adipogenesis were transfected with specific
siRNA against CSN7B. Again, adipogenesis was stim-
ulated by the hormone cocktail as described above.
Cells were analyzed by western blotting and ORO
staining after 1 and 8 days of differentiation. As
shown in Fig. 6A there were high concentrations of
Fig. 5. Transient silencing of CSN7A and
CSN7B during adipogenesis in MEFs. (A)
Adipogenesis was induced by a hormone
cocktail (see Materials and Methods).
After 7 days of differentiation cells were
lysed and analyzed by western blotting
using the indicated antibodies. (B) Lipid
droplet formation was visualized by
staining with ORO and light microscopy in
control MEFs (siGFP) and MEFs
transiently transfected with siRNA against
mouse CSN7A (siCSN7A) and CSN7B
(siCSN7B).
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PPAR-c and low of CHOP in Flag-CSN7B-LiSa-2
cells in the absence of specific siRNA as it was demon-
strated before (see Fig. 3A). In the presence of
siCSN7B, PPAR-c was reduced and CHOP increased
after 1 and 8 days of differentiation. This was accom-
panied by significantly reduced LD formation as
demonstrated by ORO staining and its quantification
in Fig. 6B, C, respectively. Transfection of Flag-
CSN7B-LiSa-2 cells with siCSN7A did not affect
accelerated adipogenesis in these cells. As demon-
strated by ORO staining in Fig. 6C in the presence of
siCSN7A the acceleration of adipogenesis in Flag-
CSN7B-LiSa-2 cells was as high as in the siGFP
control. These results show that the acceleration of
adipogenesis in Flag-CSN7B-LiSa-2 cells most likely
depends on CSN7B expression.
Conclusions
In human LiSa-2 cells at least two CSN variants coex-
ist, CSNCSN7A and CSNCSN7B. We provide evidence
that the two CSN variants might have different func-
tions in adipogenic differentiation. Although endoge-
nous CSN7B increases during adipogenesis, there is no
change in endogenous CSN7A (Fig. 2). Increased
expression of CSN7B is accompanied with an increase
Fig. 6. Transient silencing of CSN7B in
Flag-CSN7B-LiSa-2 cells during
adipogenesis. Flag-CSN7B-LiSa-2 cells
were transiently transfected with siRNA
against GFP (control), CSN7B, and CSN7A.
(A) Adipogenesis was induced and after
indicated times western blots were
performed with indicated antibodies. (B)
Transient silencing of CSN7B in Flag-
CSN7B-LiSa-2 cells during adipogenesis.
ORO staining was quantified by
photometry after 1 and 8 days of
differentiation. Data obtained from four
independent experiments are expressed
as means  SEM. Statistical significance
is indicated. (C) Flag-CSN7B-LiSa-2 cells
were transiently transfected with siRNA
against GFP (control), CSN7B, and CSN7A.
Adipogenesis was induced and after
indicated times ORO staining was
performed and lipid droplet formation was
visualized by light microscopy.
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of the CSN complex during adipogenic differentiation
[26] indicating a unique role of the CSNCSN7B variant
in adipogenesis. Moreover, overexpression of CSN7B,
but not that of CSN7A, accelerates adipogenesis.
These effects can be explained by a specific function of
CSNCSN7B variant in stimulating adipogenesis. Perhaps
CSNCSN7B preferentially binds to certain CRLs or has
a modified deneddylating activity and this promotes
adipogenesis. Recently it has been shown that CSN7
might be involved in CSN–CRL interaction leading to
induced-fit CSN activation and regulation of CRLs
[41]. This suggestion is confirmed by the observation
that CSNCSN7A and CSNCSN7B variants seem to bind
b-TrCP and USP15 with different affinities in Flag-
pulldowns (Fig. 1B).
On the other hand, downregulation of CSN7A as
well as CSN7B slowed down adipogenesis indicating
that both CSN variants are necessary for adipogenesis.
Future experiments are necessary to reveal the under-
lying mechanism of CSN7A and CSN7B effects on
adipogenesis.
Materials and methods
Cell culture and transfection
Human liposarcoma LiSa-2 cells (a gift from Wabitsch and
coworkers [39]) were used as an adipocyte differentiation
model growing in ISCOVE/RPMI (4 : 1) medium contain-
ing 10% fetal calf serum, 100 UmL1 penicillin, and
0.1 mgmL1 streptomycin as described [39]. Differentiation
was induced by culturing cells in serum-free medium with
supplements including 1 nM insulin, 20 pM triiodthyronine,
and 1 mM cortisol according to a protocol by Wabitsch
et al. [39]. During differentiation the medium was changed
every 2 or 3 days. Differentiation and formation of lipids
was monitored by ORO staining and light microscopy,
whereby nuclei were visualized with hemotoxylin [34]. ORO
was quantified according to published protocol [42]. In
brief, after washing cells four times in PBS, the ORO-
stained lipids were extracted with 4% NP-40 and 96%
isopropanol. The supernatants were measured spectropho-
tometrically at 520 nm.
Differentiated cells were harvested on different days of
differentiation as indicated and lysed with ice-cold triple-
detergent lysis buffer (50 mM Tris-HCl, pH 8.5; 150 mM
NaCl; 0.02% (w/v) sodium azide; 0.1% (w/v) SDS; 1% (v/
v) NP-40; 0.5% (w/v) sodium deoxycholate) or single-deter-
gent lysis buffer (50 mM Tris-HCl, pH 7.4; 150 mM NaCl;
1 mM EDTA, pH 8.0; 1% Triton X-100) with freshly added
PMSF (1 mgmL1) and aprotinin (10 lgmL1).
Mouse embryonic fibroblasts were retrieved from disag-
gregated embryos at embryonic day (E) 12.5–13.5 (gift
from Klaus-Peter Knobeloch) and are a standard cell
model for studying adipogenesis in vitro [40]. MEFs were
cultured at 37 °C and 5% CO2 in normal MEF culture
medium and adipogenic differentiation was induced by
change of culture medium to MEF differentiation medium.
The MEF culture medium consisted of high glucose
DulbecoMEM, 10% FCS, 100 UmL1 penicillin,
0.1 mgmL1 streptomycin, 0.2 mM glutamine, 0.1 mM
b-mercaptoethanol, and 0.2 mM nonessential amino acids.
The MEF differentiation medium was the culture medium
supplemented with 0.5 mM methylisobutylxanthine, 1 lM
dexamethasone, 10 lgmL1 insulin, and 10 lM
troglitazone.
Stable transfections with Flag-CSN7A and Flag-
CSN7B and transient transfections with siCSN7A
and siCSN7B
For stable transfection, CSN7A or CSN7B cDNA were
obtained by PCR and cloned into pCMV-3Tag-1a vector
(Stratagene, La Jolla, CA, USA) encoding 3 N-terminal
Flag-tags. These plasmids were transfected into LiSa-2
cells. Single clones were used to obtain resistant cell lines
with 0.25 mgmL1 of neomycin.
For transient transfection, human siCSN7A, siCSN7B
and siGFP (Cell Signaling, Denver, CO, USA) were trans-
fected in LiSa-2 cells or mouse siCSN7A, siCSN7B and
siGFP (Santa Cruz, Santa Cruz, CA, USA) were trans-
fected in MEF cells. After 48 h, the adipogenic differentia-
tion of LiSa-2 cells was induced by changing the culture
medium (see above). LiSa-2 cells were then harvested for
western blot analysis and for ORO staining at day 1, 8,
and 15 of differentiation. For MEFs, adipogenic differenti-
ation was induced by a change in culture medium (see
above) for 4 days, after which cells were cultured in normal
medium for another 3 days (total of 7 days) [43] and har-
vested for western blotting and for ORO staining.
Immunoprecipitation, Flag-pulldowns, glycerol
gradient, western blotting, and densitometry
Immunoprecipitations with the specific antibodies against
CSN7A (Santa Cruz) and CSN7B (Santa Cruz) were car-
ried out as stated earlier [44]. Flag-pulldowns using Flag-
CSN7A-LiSa-2 and Flag-CSN7B-LiSa-2 cells were outlined
before [37]. Just in brief, lysates were loaded onto the pre-
pared ANTI-FLAG M2 affinity column (Sigma, St. Louis,
MO, USA). After washing with 20 column volumes of 19
TBS (50 mm Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM
EDTA), proteins were eluted by competition with the Flag
peptide (100 lgmL1) as recommended by the manufac-
turer (Sigma). Eluted proteins were used for western blots.
Glycerol gradient centrifugation analysis was performed
as described [34]. Fractions with different density (5–27%
glycerol) were separated on SDS/PAGE and analyzed by
western blotting. Density gradient was standardized with
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purified human CSN (about 400 kDa, fractions 8–10). Wes-
tern blots were carried out using antibodies against Flag
(Sigma), CSN1, CSN2 (ENZO, New York, NY, USA),
CSN3 [45], CSN4 (ENZO), CSN5, CSN6, CSN7A, CSN7B
(Gene Tex, Irvine, CA, USA), CSN8 (ENZO), Cul1 (CBD
Biosciences, Franklin Lakes, NJ, USA), Cul3 (CBD Bio-
sciences), b-TrCP (Santa Cruz), USP15 (Abcam, Cam-
bridge, UK), PPAR-c, CHOP, and c-tubulin (Santa Cruz).
Densitometry was carried out using IMAGEJ software
(NIH). Statistics were calculated with GRAPHPAD INSTAT3
(Santiago, MN, USA). Error bars are standard deviations
(SD) or standard error of the mean (SEM) and unpaired
Student’s t-test was applied for statistical analysis.
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